Medicare Enrolled
Dr. Miriam Lefkowitz, MD, PHD
Internal Medicine · North Brunswick, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lefkowitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lefkowitz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lefkowitz
Dr. Miriam Lefkowitz is an internal medicine specialist in North Brunswick, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lefkowitz performed 3,920 Medicare services across 1,221 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lefkowitz received a total of $8,481 from 46 pharmaceutical and/or device companies across 747 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lefkowitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in NJ
$8,481 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,920
Medicare services
Top 8% in NJ for internal medicine
1,221
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~206 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,040 | $18 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
617 | $77 | $128 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
305 | $110 | $250 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
138 | $53 | $111 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
124 | $142 | $178 |
| Annual depression screening | 121 | $21 | $49 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
119 | $13 | $29 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
75 | $43 | $199 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
51 | $47 | $181 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
51 | $34 | $65 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
49 | $72 | $130 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
47 | $20 | $36 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
41 | $35 | $91 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
35 | $13 | $41 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $50 | $76 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
21 | $48 | $152 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
20 | $79 | $195 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $138 | $395 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
12 | $18 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,481
Total received (2018-2024)
Avg $1,212/year across 7 years
Top 9% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
747
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,265 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$215 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,326
2023
$1,309
2022
$1,286
2021
$1,160
2020
$1,146
2019
$1,056
2018
$1,198
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$307
AstraZeneca Pharmaceuticals LP
$282
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$141
ABBVIE INC.
$131
Boehringer Ingelheim Pharmaceuticals, Inc.
$94
Amgen Inc.
$80
Currax Pharmaceuticals LLC
$61
Lilly USA, LLC
$59
Abbott Laboratories
$41
Astellas Pharma US Inc
$40
PFIZER INC.
$29
Exact Sciences Corporation
$17
Sumitomo Pharma America, Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$14
WATERMARK MEDICAL, INC.
$13
Top 3 companies account for 55.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,292
AstraZeneca Pharmaceuticals LP
$1,223
ABBVIE INC.
$646
Amgen Inc.
$506
Boehringer Ingelheim Pharmaceuticals, Inc.
$488
Lilly USA, LLC
$378
Eisai Inc.
$369
PFIZER INC.
$339
AbbVie Inc.
$315
Amarin Pharma Inc.
$314
Currax Pharmaceuticals LLC
$286
ITI, Inc.
$198
Merck Sharp & Dohme Corporation
$195
Allergan, Inc.
$173
Janssen Pharmaceuticals, Inc
$169
Takeda Pharmaceuticals U.S.A., Inc.
$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$141
Bausch Health US, LLC
$135
Abbott Laboratories
$126
Allergan Inc.
$111
SANOFI-AVENTIS U.S. LLC
$110
Astellas Pharma US Inc
$94
Exact Sciences Corporation
$82
Daiichi Sankyo Inc.
$78
Novartis Pharmaceuticals Corporation
$67
Otsuka America Pharmaceutical, Inc.
$66
Kowa Pharmaceuticals America, Inc.
$55
IDORSIA PHARMACEUTICALS US INC
$44
GlaxoSmithKline, LLC.
$39
Sumitomo Pharma America, Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$28
Nalpropion Pharmaceuticals, Inc.
$26
SANOFI PASTEUR INC.
$25
EISAI INC.
$22
Boston Scientific Corporation
$21
GENZYME CORPORATION
$16
IBSA Pharma Inc.
$14
Corcept Therapeutics
$14
AbbVie, Inc.
$14
Bayer Healthcare Pharmaceuticals Inc.
$14
WATERMARK MEDICAL, INC.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Nalpropion Pharmaceuticals LLC
$13
Biohaven Pharmaceutical Holding Company Ltd.
$12
Ortho Dermatologics, a division of Bausch Health US, LLC
$11
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 37.3% of all-time payments
Associated products mentioned in payments ›
ADACEL · ADVAIR · AIRSUPRA · AJOVY · APLENZIN · ARES 620 UNICORDER · Aimovig · BREZTRI · BYSTOLIC · Belviq · CAPLYTA · CEREZYME · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cologuard Collection Kit · Creon · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GEMTESA · General - Pain Management · INJECTAFER · JANUVIA · JARDIANCE · JUBLIA · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Leqembi · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PREMARIN · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SYNJARDY · SYNTHROID · Saxenda · TOUJEO · TRADJENTA · TRINTELLIX · TRULICITY · Tirosint · Tresiba · Trintellix · UBRELVY · VIIBRYD · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
2,235
Per 100K population
259.4
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lefkowitz is a clinical cardiology specialist, with above-average Medicare volume (top 8% in NJ), with low-engagement industry engagement in the top 9% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lefkowitz experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lefkowitz performed 2,040 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lefkowitz receive payments from pharmaceutical companies?
Yes. Dr. Lefkowitz received a total of $8,481 from 46 companies across 747 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lefkowitz's costs compare to other internal medicine physicians in North Brunswick?
Dr. Lefkowitz's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lefkowitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in North Brunswick
Browse internal medicine physicians in North Brunswick ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology